Global Surgical Site Infection Control Market Growth Prospects 2024-2032

Global Surgical Site Infection Control Market Growth Prospects 2024-2032

According to Triton Market Research’s report, the Global Surgical Site Infection Control Market is expected to advance with a CAGR of 5.21% over the forecast period 2024-2032.

SURGICAL SITE INFECTION CONTROL MARKET ANALYSIS

The global surgical site infection control market has witnessed significant growth due to the increasing demand for effective infection control measures. Key players include companies specializing in surgical site infection control products and management services. These companies offer solutions such as antiseptics, surgical drapes, sutures, and advanced wound dressings to prevent and treat surgical site infections.

Effective infection control management is essential for reducing the incidence of surgical site wound infections, ensuring patient safety, and maintaining regulatory compliance. Companies are adopting advanced technologies like real-time monitoring, data analytics, and automation to enhance infection control procedures and improve outcomes. Advanced surgical site infection control providers specialize in offering customized solutions tailored to the specific needs of healthcare facilities. These services include infection control procedure optimization, surgical site infection prevention antibiotics, and comprehensive surgical site infection treatment strategies.

SURGICAL SITE INFECTION CONTROL MARKET PERFORMANCE – DRIVERS, CHALLENGES, AND OPPORTUNITIES

Escalating Incidence of Hospital-Acquired Infections

The COVID-19 pandemic and other disease outbreaks have underscored the critical role of infection prevention and control (IPC) in healthcare settings. The World Health Organization (WHO) reports that up to 70% of infections can be prevented with good hand hygiene and cost-effective practices. Despite this, the incidence of healthcare-associated infections (HAIs) remains alarmingly high. In acute-care hospitals, seven out of every 100 patients in high-income countries and 15 in low- and middle-income countries acquire at least one HAI during their stay, with 1 in 10 affected patients dying from these infections.

This escalating incidence of HAIs drives the need for advanced infection control measures. The surgical site infection control market is responding with innovative solutions, including surgical site infection control products, SSI prevention antibiotics, and comprehensive management protocols. Key players are focusing on developing and implementing these strategies to reduce infection rates and enhance patient outcomes.

Surge in Medical Waste Due to the use of Disposable Medical Items

The pandemic significantly impacted global health, leading to a surge in medical waste volumes. This increase poses new threats to human and environmental health, as highlighted by a World Health Organization (WHO) report. The extensive use of disposable medical items, such as over 140 million test kits, has generated an estimated 2,600 tons of general waste, primarily plastic, and 731,000 liters of chemical waste. While disposable medical items are crucial for preventing surgical site infections, they also contribute to substantial waste management issues, creating challenges for the studied market. Hence, companies must find a balance between effective infection control and sustainable waste management practices. To address this challenge, companies are exploring environmentally friendly materials, improved waste disposal methods, and efficient recycling processes.

Growth of Minimally Invasive and Outpatient Surgical Practices

Nevertheless, the rise of minimally invasive surgery offers a significant opportunity for the surgical site infection control market. Minimally invasive techniques, such as laparoscopy and robotic surgery, are associated with less pain, shorter hospital stays, and fewer complications than traditional open surgery. These advantages make them increasingly popular among patients and healthcare providers. Laparoscopy, a pioneering form of minimally invasive surgery, uses small incisions, tiny cameras, and surgical tools to perform operations. Robotic surgery, another advanced technique, provides surgeons with an enlarged, 3D views of the surgical site, enhancing precision and control. As minimally invasive and outpatient surgical practices grow, the need for effective surgical site infection control measures becomes crucial.

GLOBAL SURGICAL SITE INFECTION CONTROL MARKET REPORT SEGMENTATION:

Market by Procedure:

• Laparoscopy
• Orthopedic Surgery
• Cardiovascular
• Obstetrics and Gynecology
• Wound Closure
• Plastic & Reconstructive Surgery
• Thoracic Surgery
• Microvascular
• Urology
• Neurosurgery
• Other Procedures

Market by Type of Infection:

• Superficial Incisional SSI
• Deep Incisional SSI
• Organ or Space SSI

Market by Industry Vertical:

• Hospitals
• Ambulatory Surgical Centers

Hospitals, as the primary centers for surgical procedures and patient care, have a paramount need for stringent infection control measures to prevent surgical site infections (SSIs) and ensure patient safety. Across various departments, including operating rooms, emergency departments, intensive care units, and patient wards, hospitals implement comprehensive SSI control protocols. Hospitals invest significantly in a variety of SSI control products, such as disinfectants, surgical drapes, gloves, and skin preparation solutions to uphold sterile environments and reduce SSI incidence during surgical procedures.

Market by Product:

• Disinfectants

Skin Disinfectants

Hand Disinfectants

• Manual Reprocessors Solutions
• Surgical Drapes
• Surgical Gloves
• Skin Preparation Solutions
• Surgical Irrigation
• Surgical Scrubs
• Hair Clippers
• Medical Nonwovens
• Other Products

Disinfectants play a crucial role in preventing surgical site infections (SSIs) by inhibiting the growth of microorganisms on surfaces, instruments, and skin. They are essential for maintaining a sterile environment in operating rooms and other healthcare settings. Disinfectants come in various forms, including sprays, wipes, and solutions, and are formulated to target specific pathogens commonly associated with SSIs. They are rigorously tested and regulated to ensure their efficacy and safety in healthcare settings. Regular use of disinfectants as part of comprehensive infection control protocols is fundamental in minimizing the risk of SSIs and safeguarding patient health and well-being.

KEY SURGICAL SITE INFECTION CONTROL COMPANIES INSIGHTS

The companies’ insights help dive into data about the key players in the surgical site infection control market. The strategic initiatives for each of the companies considered have been covered in detail. Some of the key battery companies’ strategic initiatives are:

Business Divestment & Expansions (June 2023): STERIS Plc and Becton, Dickinson & Company

STERIS Plc entered into a definitive agreement to acquire Becton, Dickinson, and Company’s surgical instrumentation, laparoscopic instrumentation, and sterilization container assets for $540 million.

Product Launch (March 2022): Invenio

Invenio launched its V90 surgical gown series, introducing a fresh line of surgical gowns to the market.

GLOBAL SURGICAL SITE INFECTION CONTROL MARKET 2024-2032.pdf